You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,045,943


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,045,943
Title:Implantable medical devices for extended release of therapeutic agents
Abstract: The invention pertains to implantable medical devices for controlled delivery of therapeutic agents. Some devices according to the invention have a titanium reservoir, and a porous titanium oxide based membrane to control the rate of release of the therapeutic agent. The reservoir contains a formulation of the active agent, including a stabilizer for the active agent, wherein the stabilizer is provided in an extended release configuration.
Inventor(s): Roorda; Wouter Erik (Emeryville, CA)
Assignee: Nano Precision Medical, Inc. (Emeryville, CA)
Application Number:15/094,936
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,045,943: A Detailed Analysis

Introduction

Patent 10,045,943, though not specifically mentioned in the provided sources, can be analyzed using general principles and guidelines for patent scope and claims in the United States. This article will delve into the key aspects of patent claims, scope, and the patent landscape, providing a comprehensive framework for understanding any U.S. patent, including 10,045,943.

The Importance of Claim Scope

When evaluating a patent, the scope of the claims is crucial. It determines the extent of protection the patent offers and influences its validity and enforceability. A common misconception is that broader claims are always better, but this is not necessarily true[5].

Balancing Breadth and Specificity

While broader claims offer more extensive protection, they are harder to get granted and easier to invalidate. The ideal claim scope depends on several factors, including the actual invention, the level of prior art, the client’s budget, and the technical field[5].

Anchoring Claims to the Specification

Claims must be anchored to the embodiments disclosed in the specification. Overly broad claims that go beyond the specific details disclosed can be at risk of being invalidated due to the abstract idea exception or failure to meet the written description requirement[5].

Subject Matter Eligibility

The subject matter eligibility of a patent claim is a critical aspect, especially in the context of AI and software-related inventions. The USPTO's 2024 guidance update provides significant insights into this area.

Integrating Judicial Exceptions into Practical Applications

The update emphasizes the importance of evaluating whether a claim integrates a judicial exception (such as abstract ideas, laws of nature, or physical phenomena) into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

AI-Assisted Inventions

The guidance clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Examples from the USPTO Guidance

The USPTO's 2024 guidance includes examples specifically tailored to AI technologies, which can serve as a model for understanding how to craft patent-eligible claims.

Example 48: Practical Application in Speech Recognition

For instance, Example 48 illustrates how a claim involving the separation of audio components and their use in a speech recognition system to improve voice command accuracy in hands-free environments can be patent-eligible. This example shows that specifying the use of the separated audio in a real-time speech recognition system adds a practical application, making the claim eligible[1].

Patent Prosecution Process

The process of obtaining a patent involves several steps, each critical to the final outcome.

Filing a Provisional Patent Application

The patenting process often begins with filing a provisional patent application, which provides a temporary protection period and allows for further development before filing a non-provisional application[4].

Patent Examination and Claim Allowance

During the examination process, the patent examiner evaluates the claims for patentability. If the claims are not patentable as submitted, arguments and/or amended claims must be presented. If the examiner does not accept these, an appeal to an appeal board or the U.S. court system may be necessary[4].

Measuring Patent Scope

Patent scope can be measured using various metrics, which help in understanding the breadth and impact of the patent.

Independent Claim Length and Count

Research has shown that independent claim length and count can be simple yet effective metrics for measuring patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

International Patent Considerations

For inventions with global commercial potential, international patent applications are crucial.

Patent Cooperation Treaty (PCT) Applications

A PCT application preserves the right to file a patent in 153 countries within 30 months of the earliest priority date. However, due to the high costs involved, PCT applications are typically filed only for inventions with significant commercial value and near-term global licensing opportunities[4].

Key Takeaways for Patent 10,045,943

  • Claim Scope: Ensure that the claims are balanced between breadth and specificity, anchored to the embodiments in the specification.
  • Subject Matter Eligibility: Verify that the claims integrate judicial exceptions into practical applications, especially in AI and software-related inventions.
  • Patent Prosecution: Be prepared for the examination process, including potential amendments and appeals.
  • Patent Scope Metrics: Use metrics like independent claim length and count to assess the patent's scope and impact.
  • International Considerations: If applicable, consider filing a PCT application to protect the invention globally.

FAQs

Q: What is the importance of claim scope in a U.S. patent application?

A: The claim scope determines the extent of protection and influences the validity and enforceability of the patent. It must be balanced between breadth and specificity to avoid invalidation risks.

Q: How does the USPTO's 2024 guidance update impact AI-related patent claims?

A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies and emphasizes integrating judicial exceptions into practical applications to ensure patent eligibility.

Q: What metrics can be used to measure patent scope?

A: Independent claim length and count are simple yet effective metrics for measuring patent scope, correlating with various aspects such as patent maintenance payments and forward citations.

Q: What is the role of a provisional patent application in the patenting process?

A: A provisional patent application provides temporary protection and allows for further development before filing a non-provisional application, giving inventors time to refine their invention.

Q: Why is it important to consider international patent applications?

A: International patent applications, such as PCT applications, are crucial for protecting inventions with global commercial potential, preserving the right to file in multiple countries within a specified period.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Intellectual Property Protection - KU Office of Research
  5. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law

More… ↓

⤷  Subscribe

Details for Patent 10,045,943

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 June 23, 1987 10,045,943 2034-11-02
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 October 16, 1986 10,045,943 2034-11-02
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 February 04, 1999 10,045,943 2034-11-02
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 October 08, 1996 10,045,943 2034-11-02
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 August 29, 2000 10,045,943 2034-11-02
Emd Serono, Inc. SAIZEN somatropin For Injection 019764 January 16, 2007 10,045,943 2034-11-02
Ferring Pharmaceuticals Inc. ZOMACTON somatropin For Injection 019774 May 25, 1995 10,045,943 2034-11-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.